Adverse Event Reporting Rule Draws Concern About FDA's Electronic Readiness
Executive Summary
FDA's planned move to mandatory electronic filing of adverse event reports is raising some concern about its cost to small business and the agency's ability to fully integrate its growing number of electronic filing requirements